首页> 外文期刊>World Journal of Gastroenterology >Expression of albumin, IGF-1, IGFBP-3 in tumor tissues and adjacent non-tumor tissues of hepatocellular carcinoma patients with cirrhosis.
【24h】

Expression of albumin, IGF-1, IGFBP-3 in tumor tissues and adjacent non-tumor tissues of hepatocellular carcinoma patients with cirrhosis.

机译:白蛋白,IGF-1,IGFBP-3在肝细胞癌肝硬化患者的肿瘤组织和邻近的非肿瘤组织中的表达。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To explore the expression of albumin (ALB), insulin-like growth factor (IGF)-1, and insulin-like growth factor binding protein (IGFBP)-3 in tumor tissues and adjacent non-tumor tissues of hepatocellular carcinoma (HCC) patients with cirrhosis. METHODS: Twenty-four HCC patients with cirrhosis who underwent hepatectomy were studied. ALB mRNA, IGF-1 mRNA, and IGFBP-3 mRNA in liver tissues (including tumor tissues and adjacent non-tumor tissues) were detected by reverse transcriptase-polymerase chain reaction (RT-PCR). Liver Ki67 immunohistochemistry staining was studied. At the same time, 12 patients with cholelithiasis or liver angioma who underwent operation were segregated as normal control. RESULTS: In HCC patients with cirrhosis, hepatic ALB mRNA, IGF-1 mRNA, and IGFBP-3 mRNA of tumor tissues or adjacent non-tumor tissues were lower than the normal liver tissues, while in tumor tissues, hepatic ALB mRNA and IGFBP-3 mRNA were lower, hepatic IGF-1 mRNA was higher than in adjacent non-tumor tissues. Liver Ki67 labeling index (Ki67 LI) in tumor tissues or adjacent non-tumor tissues were higher than that in the normal liver tissues, while in tumor tissues it was higher than that in adjacent non-tumor tissues. CONCLUSION: Imbalance of IGF-1 and IGFBP-3 may play a role in hepatocarcinogenesis and tumor development of liver cirrhosis patients.
机译:目的:探讨白蛋白(ALB),胰岛素样生长因子(IGF)-1和胰岛素样生长因子结合蛋白(IGFBP)-3在肝细胞癌(HCC)肿瘤组织和邻近非肿瘤组织中的表达)肝硬化患者。方法:对24例肝切除的肝硬化HCC患者进行了研究。通过逆转录聚合酶链反应(RT-PCR)检测肝组织(包括肿瘤组织和邻近的非肿瘤组织)中的ALB mRNA,IGF-1 mRNA和IGFBP-3 mRNA。研究了肝Ki67免疫组织化学染色。同时,将12例接受手术的胆石症或肝血管瘤患者作为正常对照。结果:在肝硬化肝癌患者中,肿瘤组织或邻近非肿瘤组织的肝ALB mRNA,IGF-1 mRNA和IGFBP-3 mRNA低于正常肝组织,而在肿瘤组织中,肝ALB mRNA和IGFBP- 3个mRNA水平较低,肝脏IGF-1 mRNA水平高于邻近的非肿瘤组织。肿瘤组织或邻近非肿瘤组织的肝脏Ki67标记指数(Ki67 LI)高于正常肝组织,而肿瘤组织中则高于邻近非肿瘤组织。结论:IGF-1和IGFBP-3的失衡可能与肝硬化患者的肝癌发生和肿瘤发展有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号